JAPAN-Nikkei-Time to go back up? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : JAPAN-Nikkei-Time to go back up?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: borb who wrote (3264)	2/24/2003 3:20:45 PM
From: Crossy	Read Replies (1) of 3902

Borb, thx alot but this company is not right for me. ZERO revenues right now just a "venture type" biotech: "Northfield Laboratories, a development stage company, is engaged in the research, development, manufacturing, testing marketing and distribution of a hemoglobin-based blood substitute product. For the six months ended 11/30/02, the Company reported no revenues. Net loss rose 12% to $6 million. Higher loss reflects the expenses related to the proxy contest in connection with the annual meeting and lower interest income" enough for my to pass by. This is REALLY RISKY.. What I want at least are recurring sales. IF no sales then at least Price/Book of 1. This is at PRice/Book of 4 so it's not a value pick. But it's a late stage speculative bid where others got in on GROUND FLOOR. And that is exactly what I would like to - getting in on GROUND FLOOR. rgrds CROSSY

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next